← feed

Is NCT03126097 results overdue?

Yes — results are overdue. Primary completion was 2017-05-26; the FDAAA-801 reporting deadline (2018-05-26) passed 2948 days ago and no results are posted on ClinicalTrials.gov.

A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females

NCT IDNCT03126097 ↗
SponsorJanssen Research & Development, LLC (INDUSTRY)
PhasePHASE1
StatusTERMINATED
Primary completion2017-05-26 (ACTUAL)
Reporting deadline2018-05-26 (completion + 365d)
Days overdue2948
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 1d6e5cdbcf80069f… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03126097. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →